Stay updated on Flotetuzumab in PIF/ER AML Clinical Trial
Sign up to get notified when there's something new on the Flotetuzumab in PIF/ER AML Clinical Trial page.

Latest updates to the Flotetuzumab in PIF/ER AML Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedThe page revision tag was updated from v3.6.3 to v3.6.4, signaling a small backend/content update with no visible changes to the study details shown to users.SummaryDifference0.0%

- Check17 days agoNo Change Detected
- Check24 days agoNo Change Detected
- Check32 days agoChange DetectedPage build updated from v3.6.2 to v3.6.3. This reflects a new release of the page rather than content changes.SummaryDifference0.0%

- Check39 days agoChange DetectedThe page’s revision tag was updated from v3.6.0 to v3.6.2, indicating a new release of the page’s software. This update likely represents minor fixes or improvements behind the scenes rather than user-facing content changes.SummaryDifference0.0%

- Check53 days agoChange DetectedThe page was updated to show that recruitment is closed. It also adds user guidance sections (How to Read a Study Record, Common Questions, How to Join a Study) and standardizes the Intervention/Treatment heading, while updating the revision banner to v3.6.0.SummaryDifference0.3%

- Check60 days agoChange DetectedRevision label updated from v3.5.4 to v3.5.5. This reflects an updated page revision in the site's versioning system rather than a change to study data or content.SummaryDifference0.0%

- Check81 days agoChange DetectedThe page now shows a newer revision version (v3.5.4) replacing the previous v3.5.3, indicating an update to the page version without altering the underlying study data.SummaryDifference0.0%

Stay in the know with updates to Flotetuzumab in PIF/ER AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Flotetuzumab in PIF/ER AML Clinical Trial page.